anti-OX40 antibody BMS 986178
- Generic Name
- anti-OX40 antibody BMS 986178
- Brand Names
- -
- Drug Type
- Biotech
- Chemical Formula
- -
- CAS Number
- -
- Unique Ingredient Identifier
- P9XVH8H2HF
- Background
A macrocyclic peptide (BMS-986189) with activity in binding and functional assays comparable to a PD-L1 antibody.
- Associated Conditions
- -
- Associated Therapies
- -
TLR9 Agonist SD-101, Anti-OX40 Antibody BMS 986178, and Radiation Therapy in Treating Patients With Low-Grade B-Cell Non-Hodgkin Lymphomas
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2018-01-25
- Last Posted Date
- 2024-12-11
- Lead Sponsor
- Ronald Levy
- Target Recruit Count
- 14
- Registration Number
- NCT03410901
- Locations
- 🇺🇸
Stanford University, School of Medicine, Palo Alto, California, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath